-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failurePonikowski P, Voors AA, ESC Scientific Document Group. et al. -
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al.
-
Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patientsMinges KE, Herrin J, Fiorilli PN et al.
-
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRV Jeger, A Farrah, MA Ohlow et al.
-
The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk CalculatorA Khera , MJ Budoff , CJ O’Donnell et al.
-
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary DiseaseM Qintar, KH Humphries, JE Park et al.
-
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary RevascularizationH Kawashima , PW Serruys, and on behalf of the SYNTAX Extended Survival Investigators et al.
-
State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women: Indications, Performance, and LimitationsP Koilpillai, NR Aggarwal, SL Mulvagh et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
